<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The -160C/A polymorphism (rs16260) of E-cadherin, a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> repressor gene, has been shown to be a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> susceptibility allele for various types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Because the significance of this polymorphism to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk has been recognized, there are increasing studies investigating -160C/A in different types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and ethnic populations </plain></SENT>
<SENT sid="2" pm="."><plain>However, there is still uncertainty about the level of risk for a variety of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: To resolve the controversial question raised by these studies as of March 2012 and provide more statistical power for detecting the significance of -160C/A, we performed a meta-analysis of 47 case-control studies in 16 types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (18,194 cases and 20,207 controls) </plain></SENT>
<SENT sid="4" pm="."><plain>A meta-regression model and subgroup analysis were employed to identify the source of <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Publication bias was evaluated, and sensitivity analysis and cumulative evidence assessment were also performed </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Using fixed- and random-effects models, the -160AA homozygote was more susceptible to urothelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> compared with the -160CA heterozygote </plain></SENT>
<SENT sid="7" pm="."><plain>Additionally, the -160A allele is an ethnicity-dependent risk factor for prostate and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Carriers of the -160A allele in Asians and Europeans were more susceptible to <z:hpo ids='HP_0012125'>prostate cancer</z:hpo>, whereas their North American counterparts seemed tolerant </plain></SENT>
<SENT sid="9" pm="."><plain>The -160AA homozygote plays a protective role for Europeans who develop <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The stability of these observations was confirmed by a one-way sensitivity analysis </plain></SENT>
<SENT sid="11" pm="."><plain>However, the cumulative evidence for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types was considered 'weak' using the Venice guidelines </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: A meta-analysis indicated that the -160A allele of E-cadherin provides a higher risk for the development of prostate and urothelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and a protective role for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in an ethnicity-dependent manner </plain></SENT>
</text></document>